IS8138A - Gaboxadol for the treatment of depression and other psychiatric disorders - Google Patents
Gaboxadol for the treatment of depression and other psychiatric disordersInfo
- Publication number
- IS8138A IS8138A IS8138A IS8138A IS8138A IS 8138 A IS8138 A IS 8138A IS 8138 A IS8138 A IS 8138A IS 8138 A IS8138 A IS 8138A IS 8138 A IS8138 A IS 8138A
- Authority
- IS
- Iceland
- Prior art keywords
- gaboxadol
- depression
- treatment
- psychiatric disorders
- psychiatric
- Prior art date
Links
- 208000020401 Depressive disease Diseases 0.000 title 1
- ZXRVKCBLGJOCEE-UHFFFAOYSA-N Gaboxadol Chemical compound C1NCCC2=C1ONC2=O ZXRVKCBLGJOCEE-UHFFFAOYSA-N 0.000 title 1
- 229950004346 gaboxadol Drugs 0.000 title 1
- 208000020016 psychiatric disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200300956 | 2003-06-25 | ||
| DKPA200400016 | 2004-01-07 | ||
| PCT/DK2004/000459 WO2004112786A2 (en) | 2003-06-25 | 2004-06-25 | Gaboxadol for treating depression and other affective disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS8138A true IS8138A (en) | 2005-11-21 |
Family
ID=58707228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS8138A IS8138A (en) | 2003-06-25 | 2005-11-21 | Gaboxadol for the treatment of depression and other psychiatric disorders |
Country Status (10)
| Country | Link |
|---|---|
| KR (1) | KR20060025192A (en) |
| AR (1) | AR047550A1 (en) |
| CA (2) | CA2692334A1 (en) |
| CL (2) | CL2004001607A1 (en) |
| EA (1) | EA200600101A1 (en) |
| IS (1) | IS8138A (en) |
| ME (2) | ME00030B (en) |
| NO (1) | NO20060229L (en) |
| RS (1) | RS20050911A (en) |
| TW (1) | TW200509918A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019384157A1 (en) | 2018-11-21 | 2021-06-17 | Certego Therapeutics Inc. | Gaboxadol for reducing risk of suicide and rapid relief of depression |
| WO2021236876A2 (en) | 2020-05-20 | 2021-11-25 | Certego Therapeutics Inc. | Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders |
-
2004
- 2004-06-15 TW TW093117156A patent/TW200509918A/en unknown
- 2004-06-23 AR ARP040102200A patent/AR047550A1/en not_active Application Discontinuation
- 2004-06-24 CL CL200401607A patent/CL2004001607A1/en unknown
- 2004-06-25 EA EA200600101A patent/EA200600101A1/en unknown
- 2004-06-25 RS YUP-2005/0911A patent/RS20050911A/en unknown
- 2004-06-25 CA CA2692334A patent/CA2692334A1/en not_active Abandoned
- 2004-06-25 CA CA002529805A patent/CA2529805A1/en not_active Abandoned
- 2004-06-25 ME MEP-2008-19A patent/ME00030B/en unknown
- 2004-06-25 ME MEP-19/08A patent/MEP1908A/en unknown
- 2004-06-25 KR KR1020057024823A patent/KR20060025192A/en not_active Ceased
-
2005
- 2005-11-21 IS IS8138A patent/IS8138A/en unknown
-
2006
- 2006-01-16 NO NO20060229A patent/NO20060229L/en not_active Application Discontinuation
-
2010
- 2010-02-25 CL CL2010000166A patent/CL2010000166A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR047550A1 (en) | 2006-01-25 |
| KR20060025192A (en) | 2006-03-20 |
| MEP1908A (en) | 2010-02-10 |
| CL2004001607A1 (en) | 2005-05-27 |
| CL2010000166A1 (en) | 2010-07-02 |
| TW200509918A (en) | 2005-03-16 |
| EA200600101A1 (en) | 2006-06-30 |
| RS20050911A (en) | 2007-08-03 |
| CA2692334A1 (en) | 2004-12-29 |
| CA2529805A1 (en) | 2004-12-29 |
| NO20060229L (en) | 2006-01-16 |
| ME00030B (en) | 2010-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS8451A (en) | Methods and Reagents for the Treatment of Immune Inflammatory Disorders | |
| IS8410A (en) | Methods and Reagents for the Treatment of Immune Inflammatory Disorders | |
| DK1644021T3 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES | |
| DK1663978T3 (en) | Fluoro-substituted omega-carboxyaryl-diphenylurea for the treatment and prevention of diseases and disorders | |
| IS7977A (en) | Combinations and methods of combination therapy | |
| NO20032220D0 (en) | Löfteverktöy II and method for using the same | |
| DK1575597T3 (en) | Use of rimexolone for the treatment of eye dryness | |
| IS8142A (en) | Medication useful for the treatment of pain | |
| DK1660057T3 (en) | Combination therapy for the treatment of neovascular eye disorders | |
| DK1474416T3 (en) | Dihydrobenzodiazepine-2-one derivatives for the treatment of neurological disorders | |
| DK1641822T3 (en) | HETEROLOGICAL IL-17-A / F POLYPEPTIDES AND THERAPEUTIC APPLICATIONS THEREOF. | |
| DK1803718T3 (en) | 4-Tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain | |
| IS2722B (en) | 1, 2, 3, 4- Tetrasetin indole for the treatment of respiratory diseases | |
| IS7137A (en) | Combination treatment for the treatment of cancer | |
| DK1491212T3 (en) | Means for the treatment of sleep disorders | |
| NO20045554L (en) | Procedure for the treatment of diabetes | |
| DK1478438T3 (en) | Methods and compositions for the treatment of asthma | |
| DK1601744T3 (en) | ENGINEERING AND PROCEDURE | |
| DK1589973T4 (en) | Formulation and methods for the treatment of thrombocythaemia | |
| DK1599469T3 (en) | Tetrazole derivatives and methods of treating metabolism-related disorders thereby | |
| IS8497A (en) | Methods and reagents for the treatment of inflammatory diseases | |
| DK1727801T3 (en) | Piperazines useful for the treatment of pain | |
| EP1667827A4 (en) | Process for the treatment of wood | |
| IS3004B (en) | Method for the treatment of early insomnia | |
| DK1919290T3 (en) | Methods and products for the treatment of diseases |